Is RAS the Link Between COVID-19 and Increased Stress in Head and Neck Cancer Patients? by Iftikhar, Anem et al.
                                                                    
University of Dundee
Is RAS the Link Between COVID-19 and Increased Stress in Head and Neck Cancer
Patients?
Iftikhar, Anem; Islam, Mohammad; Shepherd, Simon; Jones, Sarah; Ellis, Ian
Published in:






Publisher's PDF, also known as Version of record
Link to publication in Discovery Research Portal
Citation for published version (APA):
Iftikhar, A., Islam, M., Shepherd, S., Jones, S., & Ellis, I. (2021). Is RAS the Link Between COVID-19 and
Increased Stress in Head and Neck Cancer Patients? Frontiers in Cell and Developmental Biology, 9, [714999].
https://doi.org/10.3389/fcell.2021.714999
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 17. Aug. 2021
fcell-09-714999 July 10, 2021 Time: 13:33 # 1
REVIEW



















This article was submitted to
Molecular and Cellular Oncology,
a section of the journal
Frontiers in Cell and Developmental
Biology
Received: 26 May 2021
Accepted: 25 June 2021
Published: 15 July 2021
Citation:
Iftikhar A, Islam M, Shepherd S,
Jones S and Ellis I (2021) Is RAS
the Link Between COVID-19
and Increased Stress in Head
and Neck Cancer Patients?
Front. Cell Dev. Biol. 9:714999.
doi: 10.3389/fcell.2021.714999
Is RAS the Link Between COVID-19
and Increased Stress in Head and
Neck Cancer Patients?
Anem Iftikhar, Mohammad Islam, Simon Shepherd, Sarah Jones and Ian Ellis*
Unit of Cell and Molecular Biology, The Dental School, University of Dundee, Dundee, United Kingdom
The COVID-19 pandemic emerged as a largely unexplained outbreak of pneumonia
cases, in Wuhan City, China and rapidly spread across the world. By 11th March 2020,
WHO declared it as a global pandemic. The resulting restrictions, to contain its spread,
demanded a momentous change in the lifestyle of the general population as well as
cancer patients. This augmented negative effects on the mental health of patients with
head and neck cancer (HNC), who already battle with the stress of cancer diagnosis
and treatment. The causative agent of COVID-19, SARS-CoV2, gains entry through the
Angiotensin converting enzyme 2 (ACE2) receptor, which is a component of the Renin
Angiotensin System (RAS). RAS has been shown to influence cancer and stress such
that it can have progressive and suppressive effects on both. This review provides an
overview of SARS-CoV2, looks at how the RAS provides a mechanistic link between
stress, cancer and COVID-19 and the probable activation of the RAS axis that increase
stress (anxiogenic) and tumor progression (tumorigenic), when ACE2 is hijacked by
SARS-CoV2. The mental health crises brought about by this pandemic have been
highlighted in many studies. The emerging links between cancer and stress make it
more important than ever before to assess the stress burden of cancer patients and
expand the strategies for its management.
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INTRODUCTION
COVID-19 emerged as a largely unexpected and unexplained outbreak of pneumonia cases, in
Wuhan City, China and rapidly evolved into an epidemic. In January 2020, WHO named the
causative virus as Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV2), previously
known as 2019 novel coronavirus (2019-nCOV) and declared the epidemic as a public health
Abbreviations: ACE, Angiotensin converting enzyme; ACE2, Angiotensin converting enzyme 2; ACTH,
adrenocorticotropic hormone; ARB, angiotensin receptor blockers; AT1R, angiotensin II type 1 receptor; AT2R, angiotensin
II type 2 receptor; cAMP, cyclic adenosine monophosphate; CAS, coronavirus anxiety scale; COVID-19, coronavirus
disease 2019; CRH, corticotropin releasing hormone; EGFR, epithelial growth factor receptor; EMT, epithelial mesenchymal
transition; EPAC, exchange factor directly activated by cAMP; GAD-7, generalized anxiety disorder questionnaire; HAD-A,
hospital anxiety and depression scale; HADS-D, hospital anxiety and depression scale; HNC, head and neck cancer;
HRQoL, health related quality of life; HPA, hypothalamus pituitary adrenal axis; IES-R, Impact of events scale revised;
MAPK, mitogen activated protein kinase; NFkβ, nuclear factor kappa-light-chain-enhancer of activated B cells; PI3K/AKT,
phosphatidylinositol 3-kinase/protein kinase B; PKA, protein kinase A; PTSD, post-traumatic stress disorder; RAS, renin
angiotensin system; RBD, receptor binding domain; ROS, reactive oxygen species; SARS-CoV2, severe acute respiratory
syndrome corona virus; SAS, self- rating anxiety scale; SAVE, stress and anxiety to viral epidemics; SCL-90, symptom
checklist 90; SDS, self-rating depression scale; SNS, sympathetic nervous system; TMPRSS2, transmembrane protease serine
2; TCGA, the cancer genome atlas; TGFβ 2, transforming growth factor beta 2; VEGF, vascular endothelial growth factor.
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emergency of international concern. In February 2020, this
outbreak was named as Coronavirus disease 2019 (COVID-19)
(Sun et al., 2020; Wang M.Y. et al., 2020). By 11th March 2020 the
World Health Organization declared a global pandemic. As of 1st
May 2021, there are 150,989,419 confirmed cases and 3,173,576
confirmed deaths globally reported to WHO.
The emergence of COVID-19 pandemic presented an
unprecedented global health challenge. Its ability to spread
rapidly necessitated tough lockdown restrictions, which spurred
uncertainty in all segments of society. Social isolation, physical
distancing from loved ones, closure of places of entertainment,
job losses, fear of infection, uncertainty about COVID-19
treatment effectiveness are all causes of anxiety in the general
population. Mental health and well-being have been and probably
will be, adversely affected across all age groups (Galea et al., 2020).
A meta-analysis including studies up to May 2020, indicated
that 24.4% individuals from the general population suffered
psychological distress (Cooke et al., 2020).
Head and Neck Cancer (HNC) patients already suffer
emotionally due to the unique set of challenges they face.
Significant functional, personal and cosmetic attributes are all
affected by disfiguring surgery in the region. The diagnosis itself,
debilitating course of the disease, complex treatment plans and
functional disability act as psychological stressors that reduce the
quality of life for patients with HNC (Iftikhar et al., 2021). Fear
of recurrence also weighs heavily on the patient. The COVID-19
outbreak has introduced layers of stress on top of the potentially
challenging psychological health of patients with HNC. Cancer
has been found to be a contributory factor in 20% of COVID-
19 deaths (Kuderer et al., 2020; Ng D.W.L. et al., 2020; Onder
et al., 2020; Williamson et al., 2020; Xia et al., 2020; Fung
and Babik, 2021). Early studies from the COVID-19 pandemic
indicated that 1 in 3 cancer patients suffered from psychological
distress, suggesting a higher number in comparison to pre-
pandemic studies (Klaassen and Wallis, 2021). This review looks
at how the COVID-19 pandemic has amplified stress in cancer
patients and how stress, cancer and COVID-19 may interplay,
mechanistically, via the Renin Angiotensin System (RAS).
In addition to the burdensome dynamics of a cancer diagnosis
and treatment, there are risks of severe complications of COVID-
19 infection secondary to compromised immunity due to
malignancy or the anticancer treatments. The adaptation and
re-organization of traditional health care delivery to minimize
risk of SARS-CoV2 infection, has caused significant disruption
to the delivery of cancer surgery, chemotherapy and radiation.
Some patients were unable to continue their prescribed treatment
due to the stringent lockdown measures and its socioeconomic
consequences (Gelardi et al., 2020; Ratnasekera et al., 2020).
Substitution of face-face consultations by video or phone were
also perceived as a barrier to seeking medical advice. Late
diagnosis and delays in treatment impact the survival in HNC
patients and therefore delays due to the COVID-19 pandemic
are anticipated to affect the disease outcome. All of this,
along with the recommendation for more intensive shielding,
in comparison to the general population, amplified the pre-
existing psychological burden of cancer patients (Park et al., 2020;
Figure 1).
Fear and anxiety in cancer patients during the pandemic has
been widely explored (Ng K.Y.Y. et al., 2020; Swainston et al.,
2020; Patni et al., 2021). Wang Y. et al. (2020) from China
reported that out of 6213 cancer patients, 24.4% had depression,
17.7% had anxiety, 9.3% had post-traumatic stress disorder and
13.5% had hostility. In another study by Wuhan University,
86.5% reported fear of disease progression, 65% reported anxiety
and 74.5% reported depression (Chen G. et al., 2020). Romito
et al. (2020) from Italy, reported 36% patients of lymphoma
with anxiety, 31% with depression and 36% with post-traumatic
stress disorder (PTSD), as analyzed through Hospital Anxiety and
Depression Scale (HADS-A) and (HADS-D). Increased anxiety,
insomnia and depression in breast cancer patients was observed
using the HADS, Insomnia Severity Index, Generalized Anxiety
Disorder Questionnaire (GAD-7) and Impact of Events Scale
Revised (IES-R) (Juanjuan et al., 2020; Massicotte et al., 2021).
Another study from China, including 834 patients with breast
cancer, showed a prevalence of depression, anxiety and insomnia
in 21.6, 15.5 and 14.7% of the cohort, respectively. A study from
the US, conducted an online cross-sectional survey to compare
the concerns of active cancer patients receiving treatment, to
those with cancer history but not receiving treatment, as well
as those with no history of cancer. Patients undergoing active
treatment showed greater concern about infection from SARS-
CoV2. Patients with metastatic disease felt more affected in terms
of cancer care compared to patients with non-metastatic disease
(50.8% vs. 31.0%, p = 0.02) (Lou E. et al., 2020). A study by
Ahn et al. (2020), from South Korea, utilized the Six Item Stress
and Anxiety to Viral Epidemics (SAVE) and Coronavirus Anxiety
Scale (CAS), to screen the anxiety responses of 221 patients
with breast, colorectal and gastroesophageal cancer. The study
reported 49.5% patients with anxiety responses to the COVID-
19 pandemic (Ahn et al., 2020). Albano et al. (2020) assessed the
distress levels in lung cancer patients. Of the 441 patients, 47%
showed anxiety scores of indicating a requirement for counseling.
The most commonly reported reasons for distress were fear of
contracting the virus, delayed testing and isolation (Albano et al.,
2020). Chia et al. (2021) from Singapore, identified five themes
in patients which were heightened sense of threat, impact on
healthcare experience, responsibility falling on oneself, striving
for normalcy and sense of safety and trust. The existence of
heightened threat to COVID-19 was predominant in patients
and was linked to vulnerability to COVID-19 (Chia et al.,
2021). Darlington et al. (2021) from United Kingdom, recorded
the experiences of parents of children with cancer. The study
reported that parents no longer perceived hospital as a safe place,
due to the risk of infection and expressed worry about suboptimal
cancer care (Darlington et al., 2021). Another study by Younger
et al. (2020) assessed the Health-related quality of life (HRQoL)
and reported that 72% patients showed satisfaction over quality
of care, however, the worry of COVID-19 infection was high and
emotional wellbeing was affected in 41% of patients (). Lou S.
et al. (2020) investigated the psychological state of HNC patients
undergoing radiation therapy during COVID-19, using Symptom
Checklist 90 (SCL-90), Self-Rating Depression Scale (SDS) and
Self Rating Anxiety Scale (SAS). This study reported that 37.9%
patients suffered severe anxiety. The total index scores decreased
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FIGURE 1 | Summary of the reasons for aggravated psychological stress in cancer patients. Strict lockdown measures, social isolation, delayed consultations,
suspension of mainstay treatments, fear of increased vulnerability to COVID-19 and limited access to hospital, increased the psychological stress in cancer patients.
to 3.4% following internet based psychological intervention
(Lou S. et al., 2020). A qualitative analysis by Patni et al. (2021),
included 294 patients recently diagnosed with cancer or currently
undergoing treatment. Of the 294, 40% had HNC and 22.4%
patients indicated a delay in initiating treatment attributing it to
coronavirus. In one of the surveys carried out by the Prevention
and Integrative Oncology (PRIO) by the German Cancer Society,
53.8% of HNC patients showed high stress levels, expressing
social isolation as the main concern (Büntzel et al., 2021).
These studies demonstrate the additive effect of COVID-
19 and pre-existing cancer-related anxiety, resulting in
amplification of stress in cancer patients. The subsequent
sections of this review, give an overview of SARS-CoV2,
the presence of its receptor ACE2 (a component of RAS) in
the oral tissues, the progressive and suppressive influence
of RAS on cancer (tumorigenic and anti-tumorigenic),
the progressive and suppressive influence of RAS on stress
(anxiogenic and anxiolytic) and finally how do stress, cancer and
COVID-19 interplay through RAS, when SARS-CoV2 hijacks
the ACE2 receptor.
Overview of SARS-CoV2
The causative agent for COVID-19 is the Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV2) which
belongs to the family Coronaviridae and order Nidovirales.
Coronaviruses are large enveloped, single stranded RNA viruses
that can infect humans, bats, pangolins, snakes, mice and cattle
(Weiss and Navas-Martin, 2005; Wiersinga et al., 2020). It is
believed that the initial mode of transmission for SARS-CoV2
was from animal to human, followed by human-to-human
spread. The spread between humans occurs predominantly
via respiratory droplets and contact transmission (Liu et al.,
2020; Zhang J. et al., 2020). Although not a primary route of
transmission, enclosed spaces with improper ventilation, aerosol
generating procedures and exposure to an infected person for
more than 30 min may favor airborne transmission according to
the CDC guidelines (The Lancet Respiratory Medicine, 2020).
SARS-CoV2 entry into the body is mediated by the interaction
of the viral spike protein with host cellular receptors. Among
the host receptors, Angiotensin Converting Enzyme 2 (ACE2),
is an extensively studied and recognized receptor for the
entry of SARS-CoV2 (Lan et al., 2020; Sungnak et al., 2020).
Later studies also revealed EMPPRIN (CD147/BASIGEN) as an
important receptor and route of entry for the SARS-CoV2 virus
(Radzikowska et al., 2020; Ulrich and Pillat, 2020; Wang K.
et al., 2020). Spike protein on the surface of the SARS-CoV2 is
cleaved at the S1/S2 site by the enzyme called Furin. Receptor
binding domain (RBD) in the S1 site then binds with the
receptor, ACE2, in the host cells. For SARS-CoV2 entry into
a host cell, its spike protein needs to be cleaved by cellular
protease, TMPRSS2 (transmembrane serine protease 2) at the S2
site, termed spike protein priming that exposes fusion peptides
which fuse the cell membrane (Shang et al., 2020). The receptor-
virus complex enters the cell, where it replicates, releases its
contents and infects other cells (Bestle et al., 2020; Coutard
et al., 2020; Hoffmann et al., 2020; Matsuyama et al., 2020;
Wan et al., 2020).
Clinical manifestations have been reported to vary according
to ethnicity, lifestyle factors, immune and health status (Guan
et al., 2020). However, cough and fever were the initial established
symptoms caused by the virus. Along with these, loss of
taste and smell were later recorded using the self-reported
data from the COVID-19 study app (Menni et al., 2020b).
A meta-analysis by Tong et al. (2020), on the prevalence of
these symptoms in COVID-19 patients reported gustatory and
olfactory dysfunction as an early symptom. WHO added loss of
taste and smell to the key symptoms of COVID-19 in April and
United Kingdom in May (Menni et al., 2020a). Many early case
studies reported the oral manifestations of COVID-19 leading to
altered taste sensation, oral ulcerations, necrotizing periodontal
ulcerative gingivitis, fungal infections and recurrent Herpes
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Simplex Virus 1 infection (Chaux-Bodard et al., 2020; Sinjari
et al., 2020; Dziedzic and Wojtyczka, 2021; Martín Carreras-
Presas et al., 2021; Patel and Woolley, 2021). A systematic review
of ten thousand COVID-19 cases, found the presence of oral
manifestations in 45% cases (Amorim dos Santos et al., 2021).
Giacomelli et al. (2020), conducted a cross sectional survey of the
patients admitted with SARS-CoV2 and reported taste disorders
frequently appeared before serious illness and hospitalization,
in most patients.
The expression of ACE2 receptors is found to be higher in
Asian compared to African and American people (Batlle et al.,
2020). The receptors are found in multiple organs including
the heart, vessels, gut, lungs, kidney, testis and brain (Zhang H.
et al., 2020). To understand the role of SARS-CoV2 receptors
role in the pathogenesis of COVID-19, potential route of entry
and infectivity, studies have investigated the expression of SARS-
CoV2 receptors in the oral cavity (Huang N. et al., 2020). An
early study in 2011, reported ACE2 positive epithelial cells lining
the salivary gland ducts of rhesus macaques (Liu et al., 2011).
Xu et al. (2020) analyzed bulk RNA sequence data from The
Cancer Genome Atlas (TCGA) and Functional Annotation of
The Mammalian Genome Cap Analysis of Gene Expression
(FANTOM5 CAGE) datasets and reported a high expression of
ACE2 in epithelial cells of the oral mucosa. The expression of
ACE2 was found to be higher in the tongue than in buccal
and gingival tissues. Lymphocytes in the oral mucosa also
expressed ACE2 (Xu et al., 2020). Another study, through single
cell sequence RNA database analysis, found detectable levels
of ACE2 receptors in salivary glands, but lower than those in
gastrointestinal tract, kidneys and heart muscles (Chen L. et al.,
2020). While examining the expression of RAS components
in taste buds of mice, Shigemura et al. (2019), found the
presence of renin, angiotensinogen and ACE in the taste buds
of circumvallate and fungiform papillae whereas, ACE2 was
found in the taste buds of the papillae, as well as the tongue
epithelium. Zhong et al. (2020) along with conducting single cell
sequence RNA database analysis, also investigated the expression
of ACE2 at the protein level, in different anatomical sites in the
oral cavity by immunohistochemistry (IHC) and reported a high
expression of ACE2 in the buccal mucosa, lip and tongue. This
study also reported the expression of Furin in IHC samples of
tongue, gingiva and lip (Zhong et al., 2020). A meta-analysis
by Lechien et al. (2021) reviewed the data on expression of
ACE2 and TMPRSS2 and reported expression in oral, pharyngeal
and sino-nasal human mucosa. ACE2 was expressed by basal,
apical, goblet, minor salivary and epithelial cells. TMPRSS2
was expressed by goblet and apical respiratory cells. The co-
expression of ACE2 and TMPRSS2 was found in the olfactory
region (Lechien et al., 2021).
ACE2—THE SARS-CoV2 RECEPTOR: A
COMPONENT OF THE RENIN
ANGIOTENSIN SYSTEM (RAS)
The entry receptor of SARS-CoV2, ACE2 constitutes the
protective limb of the Renin Angiotensin System (RAS).
The RAS is classically well known for its physiological and
pathological implications in cardiovascular homeostasis and
electrolyte balance (Paz Ocaranza et al., 2020). Lately it has also
been recognized for its role in the hallmarks of cancer (Wegman-
Ostrosky et al., 2015). The RAS system functions through
receptors- Angiotensin II Type 1 Receptor (AT1R), Angiotensin
II Type 2 Receptor (AT2R), and MasR effectors- Angiotensin
II, Angiotensin 1–9 and Angiotensin 1–7 and enzymes—ACE
and ACE2. Expression of RAS components has been reported
in liver, kidney, brain and the reproductive organs (Hunyady
and Catt, 2006). Studies have also reported the presence and
functionality of a local RAS in the oral cavity (Nakamura et al.,
2011; Santos et al., 2015). Classically, in response to low arterial
pressure or reduced sympathetic nervous system activity, the
juxtaglomerular cells of the kidneys produce renin (Figure 2).
Renin cleaves angiotensinogen, a hormone produced by the liver,
into Angiotensin I, which is further converted to Angiotensin
II, by Angiotensin Converting Enzyme (ACE). The binding
of Angiotensin II to Angiotensin II Type 1 Receptor (AT1R),
results in increased aldosterone production (Aguilera, 1992),
sympathetic nervous system (SNS) tone (Huang et al., 2014),
blood pressure (Iyer et al., 1996), vasoconstriction (Li et al.,
1997), Reactive Oxygen Species (ROS) (Yamada et al., 1998) and
inflammation (Wolf et al., 2002). Alternatively, the binding of
Angiotensin II to Angiotensin II Type 2 Receptor (AT2R), brings
about vasodilatation, reduction in blood pressure, fibrosis and
inflammation (Paz Ocaranza et al., 2020). ACE2, which forms
a protective axis of RAS, cleaves Angiotensin II to Angiotensin
1–7, or Angiotensin 1–9. Angiotensin 1–9 and Angiotensin
1–7 mediate their counter-regulatory and protective effects
via binding to AT2R and MasR proto-oncogene, respectively
(Paz Ocaranza et al., 2020).
RAS AND CANCER
Tumorigenic Axis
RAS has been shown to be influential in tumorigenesis through
complex interactions with several cell signaling pathways.
Paracrine signaling through local RAS components may
influence angiogenesis, apoptosis and proliferation (Deshayes
and Nahmias, 2005; George et al., 2010; Figure 3). The main
effector in tumorigenesis Angiotensin II, is produced when
Angiotensin Converting Enzyme (ACE) cleaves Angiotensin
I (Riordan, 2003). The binding of Angiotensin II to the
Angiotensin Type 1 Receptor (AT1R) leads to an increased
expression of vascular endothelial growth factor (VEGF) and
epidermal growth factor receptor (EGFR) transactivation (Chua
et al., 1998; Yang et al., 2005; Bhola and Grandis, 2008), increased
activation of the mammalian target of rapamycin (mTOR) and
mitogen-activated protein kinase (MAPK) pathways (Uemura
et al., 2005; Li et al., 2016) and increased secretion of transforming
growth factor beta 2 (TGFβ 2) (Daemen et al., 1991; Pallasch and
Schumacher, 2020). This results in angiogenic, proliferative, anti-
apoptotic and invasive tumor characteristics through the RAS.
This Angiotensin II- AT1R axis therefore works as a tumorigenic
axis (Escobar et al., 2004; Fujita et al., 2005; Ager et al., 2008;
Figure 3).
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FIGURE 2 | The Renin Angiotensin System (RAS). Reduced blood pressure results in the release of Renin from the kidneys which converts Angiotensinogen to
Angiotensin I. Angiotensin I is physiologically inactive and a precursor to Angiotensin II. Angiotensin Converting Enzyme (ACE), produced by the lungs cleaves
Angiotensin I to Angiotensin II. The binding of Angiotensin II to Angiotensin receptor Type I (AT1R) results in increased aldosterone secretion, Sympathetic Nervous
System (SNS) activation, vasoconstriction, increased blood pressure and inflammation. Its binding to Angiotensin receptor Type II (AT2R) has anti-proliferative effects.
Angiotensin II is converted into Angiotensin 1–7 by the enzyme Angiotensin converting enzyme 2 (ACE2) which is secreted by the kidney, lungs, GI tract, testes etc.
The angiotensin 1–7/Mas1 receptor complex is considered a protective axis and has anti-hypertensive, anti-proliferative and anti-inflammatory effects.
FIGURE 3 | The pro-tumorigenic and anti- tumorigenic axis of the Renin Angiotensin System (RAS). Studies have shown Angiotensin II- AT1R axis signaling to
activate EGFR, VEGF, TGF β, MAPK and NFKβ pathways leading to angiogenesis, migration, invasion and proliferation of tumor cells, thus acting as a
pro-tumorigenic pathway. ACE2- Angiotensin 1–7- MASR acts as the anti-tumorigenic axis and blocks Ang II- AT1R induced activation of EGFR, VEGF, TGFβ, MAPK
pathways.
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Suppression of the pro-tumorigenic effects of Angiotensin
II-AT1R by AT1R blocker has been demonstrated in many
cancers, including oral cancers (George et al., 2010). Hinsley
et al. (2017) reported aberrant expression of AT1R in head
and neck squamous cell carcinoma (HNSCC) and the ability
of Angiotensin II to promote tumor cell invasion. This study
also showed that the pro-tumorigenic effects of Angiotensin II
were blocked by Angiotensin 1–7 (Hinsley et al., 2017). However,
binding to Angiotensin Type 2 Receptor (AT2R) shows mixed
evidence with anti-tumorigenic effects in some studies (Li et al.,
2009; Kawabata et al., 2012; Du et al., 2013) and pro-tumorigenic
in others (De Paepe et al., 2002; Rodrigues-Ferreira and Nahmias,
2015). Matsushima-Otsuka et al. (2018) in a study on oral
squamous cell carcinoma reported an increased expression of
both AT1R and AT2R as the disease progressed, with a more
pronounced nuclear expression of AT2R associated with tumor
expression, nodal metastasis and clinical stage.
Anti-Tumorigenic Axis
ACE2, the receptor for entry of SARS-CoV2, plays a protective
role by metabolizing Angiotensin II into Angiotensin 1–7
that mediates their anti-tumorigenic effects via binding to
MasR (Figure 3). These anti-tumorigenic effects of ACE2/Ang
1–7/MasR axes are through the inhibition of proliferation,
angiogenesis, tumor growth and invasion (Feng et al., 2010, 2011;
Xu et al., 2017). Studies in various cancers have shown that
Angiotensin 1–7 induced inactivation of phosphatidylinositol 3-
kinase/protein kinase B (PI3K/Akt), MAPK and VEGF signaling
pathways (Machado et al., 2000; Benndorf et al., 2003; Gallagher
and Tallant, 2004; Cook et al., 2010; Ni et al., 2012; Zhang
et al., 2019). A profiling analysis of various cancers by Dai et al.
(2020) showed a positive correlation between ACE2 expression
and survival prognosis in liver cancer only. Another study using
data from The Cancer Genome Atlas, found high levels of ACE2
expression in primary tumors compared to normal adjacent
tissue (Winkler, 2020). A bioinformatic analysis by Huang X.
et al. (2020) found an association between ACE2 and immune cell
infiltration in various cancer tissues. Zhang Z. et al. (2020) also
performed a computational analysis of various cancers including
head and neck cancers using The Cancer Genome Atlas (TCGA)
to investigate the association between expression of ACE2
receptor and oncogenic pathways, tumor phenotype and clinical
outcomes. The study reported that ACE2 upregulation was
associated with increased anti-tumor immune signatures and was
inversely correlated with TGFβ, Wnt/β-catenin, VEGF and Notch
signaling pathways. The expression of ACE2 was also inversely
correlated to stemness, proliferation and epithelial mesenchymal
transition (EMT). Siljee et al. (2020) investigated the expression
of RAS components in cancer stem cells of head and neck
malignant, metastatic melanoma and found the expression of the
pro renin receptor (PRR), ACE and AT2R in all and renin in one
of the tissues. ACE2 mRNA expression was reported, but none
of the 20 tissues expressed ACE2 protein. Nallaiah et al. (2019)
investigated the expression of RAS components in cancer stem
cells of the moderately differentiated head and neck cutaneous
squamous cell carcinoma. AT2R, AT1R, PRR, and ACE were
expressed throughout the tumor microenvironment in all the
tumor nests, peritumoral stroma and the microvessels within the
tumor nests (Nallaiah et al., 2019). The expression of the RAS
components was also reported in cancer stem cells of moderately
differentiated squamous cell carcinoma of the lip and buccal
mucosa (Featherston et al., 2016; Ram et al., 2017).
Along with ACE2, Sacconi et al. (2020) also investigated the
expression of TMPRSS2 in head and neck cancer tissues using
the TCGA. The study reported reduced expression of TMPRSS2
in HNC tissues. Reduced TMPRSS2 expression was associated
with mutated p53 and HPV negative status of tumors (Sacconi
et al., 2020). Another study using TCGA reported increased
expression of ACE2 and TMPRSS2 in lung and oral cancer
tissues from smokers which may indicate increased susceptibility
of smokers to COVID-19 because of the increased expression
of binding receptors for SARS-CoV-2, however there is not
enough data from immunohistochemistry on patient tissues
(Chakladar et al., 2020).
RAS AND HALLMARKS OF STRESS
Anxiogenic Axis
Early evidence shows the link between RAS and psychogenic
stress (Gaillard et al., 1981; Ganong, 1993; Figure 4). Social
isolation, a consequence of both HNC and the current
COVID-19 restrictions, is strongly associated with stress and
is considered a risk factor for morbidity (Dickerson et al.,
2011). In terms of RAS, a study also reported increased
plasma renin in response to the chronic stress induced by
living alone (Terock et al., 2017). Human studies investigating
the response of RAS to mild acute mental stress also found
increased plasma renin (Kosunen et al., 1976; Hamer et al.,
2011). Gideon et al. (2020) reported that acute psychosocial
stress in the form of Tier Social Stress Test (TSST), increased
plasma renin, plasma and salivary aldosterone and salivary
cortisol levels.
Chronic anxiety and stress are translated in the body by
increased levels of pituitary and adrenal hormones, as well
as catecholamines via the hypothalamus pituitary adrenal axis
(HPA) and SNS (Glaser and Kiecolt-Glaser, 2005; Jacobson,
2014). Few studies have reported the direct effects of COVID-
19 on the HPA axis, however, a recent study showed HPA to
be rich in ACE2 receptors and TMPRSS2 (Chigr et al., 2020).
Yang et al. (1996) showed that stress stimulated the circulating
levels of angiotensin II. Angiotensin II has been shown to
increase fear and anxiety by activating AT1R (Saavedra and
Benicky, 2007; Krause et al., 2011; Marvar et al., 2014). Stress
also increased the expression of AT1R and AT2R in the adrenal
cortex, adrenal medulla and pituitary glands (Armando et al.,
2001; Leong et al., 2002). The binding of Angiotensin II to AT1R
stimulates the secretion of catecholamines, adrenocorticotropic
hormone (ACTH), corticotropin releasing hormone (CRH), and
corticosterone by activating the HPA axis and SNS (Ganong
et al., 1987; Aguilera et al., 1995; Saavedra et al., 2005). The
increased levels of glucocorticoids in response to stress, in turn
increase the expression of AT1R by stimulating the GRE in the
receptor promotor region (Guo et al., 1995). It was found that
blockade of AT1R with AT1R antagonists, inhibited the CRH-
induced ACTH and corticosterone (Armando et al., 2001; Raasch
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FIGURE 4 | Anxiogenic and Anxiolytic axes of the Renin Angiotensin System (RAS). Increased psychological stress results in increased circulating levels of
Angiotensin II, which can increase the adverse effects of Angiotensin II-/AT1R signaling. Angiotensin II/AT1R has been found to increase CRH and ACTH levels, as
well as increase SNS tone and thus act as an anxiogenic axis. ACE2-/Angiotensin 1–7/MasR is found to be anxiolytic by dampening the HPA axis activation in
response to stress. CNS-(Central Nervous System, CRH (Corticotropin releasing hormone), ACTH (Adrenocorticotropic hormone), SNS (Sympathetic nervous
system), 11β HSD-1 (11 β hydroxysteroid dehydrogenase type 1), 11β HSD-2 (11 β hydroxysteroid dehydrogenase type 2).
et al., 2006), and chronic mild stress (Saavedra and Benicky,
2007; Pratap et al., 2011). The Norwegian HUNT study compared
the depressive symptoms of a large population of patients with
systemic hypertension taking ACE inhibitors vs. those with
untreated hypertension. The results showed depression-reducing
effects of ACE inhibitors independent of hypertensive effects
(Johansen et al., 2012). These studies show that the Angiotensin
II- AT1R axis acts as anxiogenic, such that stress increases the
levels of Angiotensin II and its binding with AT1R increases the
levels of stress hormones (Figure 4).
Anxiolytic Axis
Whereas studies show an anxiogenic effect of the Angiotensin-
AT1R axis, ACE2 has been reported to dampen stress and anxiety
related disorders via signaling through the MasR receptor and
thus has an anxiolytic activity (Wang et al., 2016; Cahill et al.,
2019; Figure 4). Increased levels of ACE2 were found in patients
using ACE inhibitors or Angiotensin Receptor Blockers (ARB)
(Furuhashi et al., 2015). Over-expression of ACE2 was linked to
increased MasR receptors in the amygdala, a region of the brain
that controls fear and anxiety (Davis, 1992). Wang et al. (2016),
showed that over-expression of ACE2 in mice, was associated
with anxiolysis by stimulating the MasR receptors. Wang
et al. (2018) also showed that mice over-expressing ACE2 had
lower plasma corticosterone levels, blunted HPA axis activation
and reduced anxiety-like behavior. Studies have shown that
ACE2/Angiotensin 1–7/MasR represents a promising therapeutic
target for treatment of anxiety disorders and depression.
HOW DO STRESS, CANCER, AND RAS
INTERPLAY WHEN SARS-CoV2 HIJACKS
ACE2?
The presence of SARS-CoV2 in the community and merely
the thought of being infected, may generate fear and anxiety,
the full impact of which may only unfold with the passage of
time. The studies referenced above suggest that the COVID-19
pandemic has increased stress levels in the general population,
as well as in patients with cancer. However, there might
appear to be a dearth of studies aimed specifically at patients
with HNC, to understand the effects of stress on disease
progression during the COVID-19 pandemic, and any resulting
effect on symptoms.
Many studies have shown increased levels of circulating
catecholamines and cortisol in HNC (reviewed in Table 1, Iftikhar
et al., 2021). In terms of COVID-19, levels of cortisol and
HADS score were significantly increased in patients who died of
COVID-19 (Ramezani et al., 2020). Studies have also pointed out
the possibility of using cortisol levels as biomarkers of serious
illness due to COVID-19 (Tan et al., 2020).
SARS-CoV2 uses both the protective and adverse arms of
the RAS to its advantage. To gain access into the body, it
must bind to the ACE2 receptor. Once it is inside, ACE2
is internalized and becomes downregulated to carry out its
protective anti-tumorigenic and anxiolytic functions and as a
result there are increased levels of Angiotensin II with increased
AngII-AT1R signaling (Figure 5). Since the evidence of ACE2
expression in tumors is mixed, with some studies showing
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FIGURE 5 | The interplay between SARS CoV-2, cancer progression and stress via the Renin Angiotensin System (RAS). Hijacking of ACE2 receptor by SARS-CoV2
may compromise the protective arm of the Renin Angiotensin System (RAS), by creating a deficiency of ACE2. As a result, there is an increased level of Angiotensin
II, since it is not cleaved by ACE2 to Angiotensin 1–7 (black cross). This causes an increase in the pro-tumorigenic and anxiogenic- Angiotensin II- AT1R signaling,
which increases the stress hormones and activates the oncogenic pathways. These pathways not only progress the tumor but are also used for replication of
SARS-CoV2. Again, due to the deficient ACE2, the axis- ACE2/Angiotensin 1–7/MasR cannot counteract the effects of ANGII-AT1R signaling and unable to block
the oncogenic pathways (Green cross) as well as the increased levels of stress hormones (blue cross) and (red cross).
FIGURE 6 | Direct and indirect effects of stress on tumor progression and COVID-19. Stress hormones have direct effects on cancer progression by increasing
angiogenesis, cell proliferation, migration, cell survival and DNA damage. The indirect effects of stress may be seen in the adoption of habits such as increased
alcohol consumption and cigarette smoking, which aid cancer progression. The direct effects of stress on COVID-19 are through immune dysregulation, increased
Angiotensin II levels and activation of pathways required for SARS-CoV2 replication. The indirect effects involve adoption of unhealthy lifestyle factors such as
increased alcohol intake, smoking and altered sleep patterns.
increased expression, while others showing decreased expression,
it is easy to speculate that low expression may act as a COVID-
19 protective mechanism for cancer patients (Siljee et al., 2020;
Winkler, 2020). However, at the same time, conditions with
deficient ACE2 already, may pose a greater threat if the available
ACE2 also gets hijacked.
To replicate, SARS-CoV2 requires EGFR, PI3K, MAPK, TGFβ
and nuclear factor kappa-light-chain-enhancer of activated B
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cells (NFkβ) pathways (Hemmat et al., 2021), activated by
the adverse arm, Angiotensin II- AT1R, which has anxiogenic
and pro-tumorigenic effects (Chua et al., 1998; Wolf et al.,
2002; Hunyady and Catt, 2006; Bhola and Grandis, 2008).
Increased circulating levels of Angiotensin II increase the levels
of cortisol and SNS activation. These stress hormones further
aid tumor progression and replication of the virus directly,
by activating some of the pathways and by increasing the
levels of Angiotensin II, leading to the angiotensin II-AT1R
signaling (Figure 5).
Stress has always been an unavoidable element in the
balance between health and disease. The SARS-CoV2 virus
reminds us of the direct and indirect effects of stress on
different systems and diseases. Studies have highlighted the role
of stress hormones in cancer progression by influencing cell
proliferation, angiogenesis, invasion, migration, cell survival,
immune dysregulation and DNA damage (Iftikhar et al., 2021).
The indirect effects of stress may be seen in the adoption of habits
such as increased alcohol consumption and cigarette smoking,
which aid cancer progression (Figure 6). Studies have shown
that cortisol released by stress-induced HPA axis dysregulation
is associated with alcohol misuse (Dunlavey, 2018). Although
HNC are considered to be amongst the most stressful cancers and
closely associated with alcohol and smoking, surprisingly studies
do not highlight stress as a direct or indirect factor in the etiology
or progression of HNC.
In terms of COVID-19, stress serves to elevate circulating
levels of Angiotensin II and aids in the activation of pathways
needed for replication and increase in the viral load (Yang
et al., 1996). The effects of stressors on the immune system and
diminished response to vaccines have also been seen in viral
infections (Glaser and Kiecolt-Glaser, 2005). Acute stress has
been shown to activate NFkβ (Kuebler et al., 2015). Studies have
also shown the stress hormones to activate PI3K and MAPK
via cyclic adenosine monophosphate (cAMP), activated protein
kinase A (PKA) and exchange factor directly activated by cAMP
(EPAC) effector pathways, reviewed in Iftikhar et al. (2021). The
indirect effects can lead to the adoption of unhealthy lifestyle
with altered sleeping patterns, alcohol misuse and smoking
which increase the susceptibility to infection, as well as decrease
the effectiveness of vaccines (Glaser and Kiecolt-Glaser, 2005;
Figure 6).
CONCLUSION
Deteriorating mental health was already a challenge of the
twenty-first century and has now been amplified by the pandemic
that has changed the world its people were accustomed to. The
adaptation to the new normal has been an additional source
of emotional turmoil for the general population but more so
for cancer patients who not only had to reset their way of
living, but also deal with the disruption in their diagnosis and
ongoing treatment. In the last two decades, scientific activity
has increased the efforts to determine the effect of stress on
cancer progression, but comparatively fewer studies are seen
in HNC even though they are considered to be amongst the
most stressful cancers due to the anatomical, cosmetic and
functional importance of this region. With the pandemic hitting
the world and affecting mental health, the need to understand
the impact of psychological stress on cancer progression has
been underscored.
Through this review we found that fear and anxiety has
been/is being widely explored in cancer patients during the
pandemic, yet again only a few studies have reported the impact
of the pandemic on the mental health of patients with HNC
so far. In addition to the direct effects that stress may have
on COVID-19 and cancer, it also reminds us of the indirect
effects that lead to lifestyle choices which progress COVID-
19 and HNC.
In the light of the referenced studies, this review summarized
the interaction between RAS and cancer, RAS and stress and
presents an insight on how stress, cancer and COVID-19 may
interact mechanistically through RAS and facilitate each other’s
progression when SARS-CoV2 hijacks ACE2. As a result of this
hijacking, the protumorigenic and anxiogenic signaling through
Angiotensin II- AT1R is increased, which in turn may lead
to the activation of signaling pathways required for SARS-
CoV2 replication.
Considering HNC are psychologically very stressful, there is
an urgent need to investigate the impact of COVID-19 on stress
burden in patients with HNC and expansion of strategies for
its management. Furthermore, studies may look at how this
increased psychological stress has impacted disease progression
and which symptoms have been affected the most. Alongside,
in vitro studies are also important to determine if increased levels
of stress affect the expression of the entry receptor for SARS-
CoV2 in HNC tissues and cells, to establish if stress makes HNC
more prone to COVID-19 in addition to its effect on the immune
system and lifestyle.
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